title: Dopamine agonist switching in Parkinson's disease.
abstract: There are a number of situations for patients with Parkinson's disease in which a safe and efficacious switch from treatment with one dopamine agonist to another may be required. This article explores reasons for making such a switch, and provides practical guidance on performing it.
authors.affiliation: Victoria Infirmary, Glasgow G42 9TY.
authors.forename: David
authors.initials: D
authors.lastname: Stewart
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Morgan
authors.forename: David
authors.initials: D
authors.lastname: Burn
authors.forename: Donald
authors.initials: D
authors.lastname: Grosset
authors.forename: K Ray
authors.initials: KR
authors.lastname: Chaudhuri
authors.forename: Douglas
authors.initials: D
authors.lastname: MacMahon
authors.forename: Fiona
authors.initials: F
authors.lastname: Needleman
authors.forename: Graeme
authors.initials: G
authors.lastname: Macphee
authors.forename: Peter
authors.initials: P
authors.lastname: Heywood
mesh_terms: D003142:Communication; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010817:Physician-Patient Relations
chemical_list: D018491:Dopamine Agonists